Omniscient’s proprietary platform Quicktome has been approved by the US Food and Drug Administration and is already in use at ...

NRF is co-leading the round with OIF Ventures, taking a preferred equity stake in the ongoing $36 million Series D.

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...

CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Omniscient (“o8t®”), a global pioneer in the use of AI to decode the human brain, ...

A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...

Researchers used single-nucleus multiomics to map gene expression and regulation across three brain regions in sporadic early ...

A new study led by researchers at UTHealth Houston investigated both gene expression and regulation at single cell levels to ...

CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Omniscient ("o8t (R)"), a global pioneer in the use of AI to decode the human brain, today announced the issuance of a new Category III Current Procedural ...

Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-tech innovation and AI-powered multimodal systems, today announced that its China-based ...

Researchers at Polytechnique Montréal have succeeded in mapping blood flow in the brain with unprecedented precision, which ...

Scientists preparing to simulate human brain on a supercomputer could transform neuroscience, AI, and medicine. Discover how ...

Precision Neuroscience Corporation (Precision) today announced a strategic partnership with Medtronic to advance neurosurgery, leveraging Precision’s brain – computer interface (BCI) technology and ...